Ainos Inc

NAS:AIMD (USA)  
$ 0.83 -0.0366 (-4.22%) 07:08 PM EST
At Loss
P/B:
0.22
Enterprise V:
$ 10.06M
Volume:
208.89K
Avg Vol (2M):
914.75K
Trade In:
Volume:
208.89K
At Loss
Avg Vol (2M):
914.75K

Business Description

Description
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
Name Current Vs Industry Vs History
Cash-To-Debt 0.18
Equity-to-Asset 0.76
Debt-to-Equity 0.25
Debt-to-EBITDA -0.6
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.2
Distress
Grey
Safe
Beneish M-Score -10.69
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 42.3
9-Day RSI 43.87
14-Day RSI 43.9
6-1 Month Momentum % -55.98
12-1 Month Momentum % -72.64

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.32
Quick Ratio 0.28
Cash Ratio 0.22
Days Inventory 401.38
Days Sales Outstanding 160.5

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -102.8
Shareholder Yield % 82.21
Name Current Vs Industry Vs History
Gross Margin % -220.21
Operating Margin % -14695.75
Net Margin % -15495.75
FCF Margin % -5087.23
ROE % -52.95
ROA % -43.82
ROIC % -43.3
ROC (Joel Greenblatt) % -1214.32
ROCE % -45.98

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 37.73
PB Ratio 0.22
EV-to-EBIT -0.7
EV-to-EBITDA -1.06
EV-to-Revenue 106.98
EV-to-FCF -2.1
Earnings Yield (Greenblatt) % -142.86
FCF Yield % -88.57

Financials (Next Earnings Date:2024-08-09 Est.)

AIMD's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AIMD

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Ainos Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.094
EPS (TTM) ($) -3.33
Beta 2.34
Volatility % 85.23
14-Day RSI 43.9
14-Day ATR ($) 0.111689
20-Day SMA ($) 0.89734
12-1 Month Momentum % -72.64
52-Week Range ($) 0.7749 - 6.1
Shares Outstanding (Mil) 6.5

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ainos Inc Filings

Filing Date Document Date Form
No Filing Data

Ainos Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Ainos Inc Frequently Asked Questions

What is Ainos Inc(AIMD)'s stock price today?
The current price of AIMD is $0.83. The 52 week high of AIMD is $6.10 and 52 week low is $0.77.
When is next earnings date of Ainos Inc(AIMD)?
The next earnings date of Ainos Inc(AIMD) is 2024-08-09 Est..
Does Ainos Inc(AIMD) pay dividends? If so, how much?
Ainos Inc(AIMD) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1